RNA Leaders

We focus on developing novel RNA-centered approaches to addressing unmet medical needs. SomaGenics' research and development has been supported by over $20M in competitive grants and it is our policy to publish the results of our efforts in respected peer-reviewed journals. Our staff includes internationally recognized leaders in RNA research and technology development. Learn more...

more about SomaGenics

Latest from SomaGenics


SomaGenics awarded NIH funding to develop NGS Single-Cell analysis of small RNAs

Santa Cruz, CA, October 2017- SomaGenics announced the receipt of a Phase I SBIR grant from NIH to develop RealSeq®-SC (Single Cell), expected to be the first commercially available library...

Read more

SomaGenics is a privately held biotech company with offices and laboratories located in Santa Cruz, CA. We specialize in small RNA technologies, including innovative RNAi-based therapeutics using sshRNA molecules, and diagnostics/biomarker detection of small or fragmented RNA, including microRNAs.

learn more